Covalently linking different therapeutic modalities together delivers new scaffolds with enhanced therapeutic activity. Creating these entities requires the development of highly selective biocompatible chemistries to bring the basic building blocks together. The Bloom lab aims to create a suite of new synthetic reactions to generate defined macromolecular structures composed of two or more modalities, i.e., bio-hybrids, that address human disease.
